Send feedback

AGXT p.Pro11His

c.32C>A · rs34116584 · VCV204018

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 6 submitters
AlphaMissense
ambiguous
0.4996 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0736%, eas)
Conditions
2
primary hyperoxaluria type 1

Computational evidence

Protein change
AlphaMissense0.4996ambiguous
REVEL0.557indeterminate
SaProtLLR -12.65damaging
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.3GERP 1.3, phastCons 1
Regional constrainto/e 1.00unconstrained · MANE · 9,952 bp · p 0.92 · regional, not allelic
Overall
CADD23.3PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0736% East Asian · 33/44,862 alleles
Filtering AF 0.0648% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0632%
Overall 0.0582% 938/1,612,894 alleles · ultra-rare
Ancestry group Frequency 1 in
East Asiangrpmax 0.0736% 1,359
European (non-Finnish) 0.0687% 1,455
Remaining individualsnot grpmax-eligible 0.056% 1,785
Admixed American 0.0317% 3,157
South Asian 0.0242% 4,138
African / African-American 0.024% 4,170

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
AGXT
Protein
p.Pro11His
Coding
c.32C>A
MANE Select
NM_000030
dbSNP
rs34116584
Type
single nucleotide variant
Location
chr2:240868897 (GRCh38)
Gene constraint
LOEUF 1.251 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 98.30 · 17 PDB
Residue 11
an α-helix; a UniProt-annotated variant site (in allele minor; associated in cis with m-340; decreased specific alanine--glyoxylate aminotransferase activity in vitro when associated with m-340; loss of alanine--glyoxylate aminotransferase activity in vitro when associated with i-152 and m-340; loss of alanine--glyoxylate aminotransferase activity in vitro when associated with r-170 and m-340; loss of alanine--glyoxylate aminotransferase activity in vitro when associated with t-244 and m-340; causes mitochondrial mistargeting when associated with r-170 and m-340)
Full AGXT gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

primary hyperoxaluria type 1 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: alanine glyoxylate aminotransferase deficiency

For Primary hyperoxaluria (Orphanet):

Inheritance
Autosomal recessive
Onset
All ages
Prevalence
1-9 / 1 000 000 (Germany)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/agxt-p-pro11his (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown